What is Allena Pharmaceuticals, Inc. (ALNA) stock price today?

Allena Pharmaceuticals, Inc. (ALNA) is currently trading at $0.08, up 14.29% today.

What is ALNA P/E ratio?

Allena Pharmaceuticals, Inc.'s P/E ratio is -0.08. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is ALNA return on equity (ROE)?

Allena Pharmaceuticals, Inc.'s return on equity (ROE) is -173.68%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

NASDAQ · Biotechnology

Allena Pharmaceuticals, Inc. (ALNA) Stock

$0.08 +14.29% NASDAQ: ALNA Healthcare

Allena Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and market introduction of orally administered enzyme therapies.

Valuation

Metric	Value
Price	$0.08
Market Cap	$0
P/E Ratio	-0.08
P/B Ratio	0.13
P/S Ratio	0.00
EPS (TTM)	$-1.03
52-Week High	—
52-Week Low	—
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-173.68%
ROA	-94.29%
ROCE	-169.49%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.05
Current Ratio	2.06

Annual Financials (USD)

Metric	2017	2018	2019	2020	2021
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-21.0M	$-36.0M	$-47.0M	$-32.0M	$-32.0M
Net Profit	$-22.0M	$-36.0M	$-47.0M	$-33.0M	$-33.0M
EPS	$-4.79	$-1.72	$-2.13	$-1.01	$-1.03
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2017	2018	2019	2020	2021
Total Assets	$96.0M	$65.0M	$34.0M	$39.0M	$35.0M
Total Liabilities	$13.0M	$16.0M	$17.0M	$16.0M	$16.0M
Cash	$94.0M	$62.0M	$30.0M	$35.0M	$30.0M
Borrowings	$9.0M	$10.0M	$10.0M	$10.0M	$1.0M

Latest News

Micron and Sandisk Are Surging: Can the Rally Last Through 2027? Motley Fool · Jul 23, 2026 Net Asset Value(s) Business Wire · Jul 23, 2026 Retiring With Lots of Savings? 2 Social Security Claiming Strategies to Look At. Motley Fool · Jul 23, 2026 Arista Networks Insider Sold Shares Worth $7,388,872, According to a Recent SEC Filing MT Newswires · Jul 23, 2026 Go Global, Go Systemic: China Asset Management Unveils Active Investment Research 5.0 GlobeNewswire · Jul 23, 2026

Cash Flow (USD)

Metric	2017	2018	2019	2020	2021
Operating Cash Flow	$-21.0M	$-32.0M	$-44.0M	$-28.0M	$-46.0M
Investing Cash Flow	$23.0M	$-1.0M	$0	$-1.0M	$-1.0M
Financing Cash Flow	$67.0M	$-1.0M	$12.0M	$34.0M	$41.0M
Net Cash Flow	$69.0M	$-33.0M	$-32.0M	$5.0M	$-5.0M
Free Cash Flow	$-21.0M	$-32.0M	$-44.0M	$-29.0M	$-46.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	0.92
FCF Yield	—
Quick Ratio	2.11
Interest Coverage	-63.40
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
APGNApexigen, Inc.	$0.39	+8.48%	-0.24	$9.57M	0.00%
CHROChannel Therapeutics Corporation	$1.35	+7.14%	-0.05	$8.90M	0.00%
CRVOCervoMed Inc.	$3.22	-1.83%	-0.94	$29.81M	0.00%
CSCICOSCIENS Biopharma Inc.	$2.72	+0.00%	-0.35	$8.57M	0.00%
EPIXESSA Pharma Inc.	$0.20	-1.85%	-0.87	$9.52M	0.00%

About Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and market introduction of orally administered enzyme therapies. Operating within the United States, the firm is dedicated to addressing debilitating metabolic and renal conditions, particularly those that are rare and severe. Its primary therapeutic candidate, ALLN-346, is an innovative enzyme designed to break down urate. This treatment is specifically aimed at individuals experiencing hyperuricemia and gout, especially when these conditions coexist with advanced chronic kidney disease. Established in 2011, Allena Pharmaceuticals maintains its corporate headquarters in Newton, Massachusetts.

the stock is valued at a negative price-to-earnings (P/E) ratio of -0.08, reflecting a net loss over the last twelve months, price-to-book of 0.13, price-to-sales of 0.00.

On profitability, Allena Pharmaceuticals, Inc. generates a return on equity (ROE) of -173.68% (negative, reflecting a net loss), return on capital employed of -169.49%.

Official website: www.allenapharma.com